Clinical Trial Update: Triomune Bioequivalence With Innovators [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated the bioequivalence of Triomune to the innovator product in people with HIV/AIDS; results were posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Aids

Drugs mentioned

• Innovator lamivudine/stavudine fixed-dose combination (lamivudine/stavudine)
• Triomune (lamivudine/stavudine)

Snippet

Sponsor: Makerere University | Conditions: HIV/AIDS | Phase 4 | Status: COMPLETED | Results posted: 2009-12-04